Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Pharmacopsychiatry|June 14, 2003
Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatmentW Löffler, R Kilian, M Toumi, et al.Acta Psychiatrica Scandinavica|July 6, 2004
Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychoticsR Kilian, S Dietrich, M Toumi, et al.L'Encephale|June 12, 1998
[Cost of illness: an inextricable maze or an aid in decision making? The case of schizophrenia]R Launois, M Toumi, J Reboul-Marty, et al.Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|November 24, 2004
Infrared and polarized Raman spectra of a noncentrosymmetric compound "sodium samarium fluorosilicate" NaSmSiO4.0.25NaFA Dakhlaoui, M Toumi, L S Smiri, et al.Acta Psychiatrica Scandinavica|October 7, 2006
The impact of caregivers' characteristics, patients' conditions and regional differences on family burden in schizophrenia: a longitudinal analysisC Roick, D Heider, M Toumi, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
A pharmacoeconomic evaluation of escitalopram, a new selective serotonin reuptake inhibitor. Comparison of cost-effectiveness between escitalopram, citalopram, fluoxetine, and venlafaxine for the treatment of depression in NorwayC François, M Toumi, A-M Aakhus, et al.The European Respiratory Journal|November 1, 1990
Manufacturer's information insert and subjective theophylline side-effectsD Vesco, M Toumi, F Faraj, et al.Psychiatry Research|January 26, 2000
Evaluation of depression in schizophrenia: psychometric properties of a French version of the Calgary Depression ScaleC Lançon, P Auquier, G Reine, et al.Journal of Medical Economics|November 9, 2021
Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the NetherlandsJ A Spoorendonk, J-B Briere, K Bowrin, et al.Natural Product Research|July 25, 2015
Activity antifungal of the essential oils; aqueous and ethanol extracts from Citrus aurantium LN Metoui, S Gargouri, I Amri, et al.Pageof 6